Non-Hodgkin's lymphoma of mucosa-associated lymphoid tissue

Oncologist

Volumn 11, Issue 10, 2006, Pages 1100-1117

  Cohen, Seth M ^a,c   Petryk, Magdalena ^a,c   Varma, Mala ^a,c   Kozuch, Peter S ^a,b,c   Ames, Elizabeth D ^a   Grossbard, Michael L ^a,b,c  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

^c Institute for Head and Neck and Thyroid Cancer   (United States)

Author keywords

Helicobacter pylori; Mucosa associated lymphoid tissue; Non Hodgkin's lymphoma

Indexed keywords

ALKYLATING AGENT; AMOXICILLIN; BISMUTH SALICYLATE; CHLORAMBUCIL; CLADRIBINE; CLARITHROMYCIN; CYCLOPHOSPHAMIDE; DOXYCYCLINE; METRONIDAZOLE; PROTON PUMP INHIBITOR; RITUXIMAB; TETRACYCLINE;

ANTIBIOTIC THERAPY; CANCER RESEARCH; CANCER STAGING; CLINICAL FEATURE; CLINICAL TRIAL; CYTOGENETICS; DISEASE CLASSIFICATION; GASTRECTOMY; HELICOBACTER INFECTION; HUMAN; IMMUNOPHENOTYPING; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHODGKIN LYMPHOMA; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY TRACT MUCOSA; REVIEW; SKIN LYMPHOMA; STOMACH LYMPHOMA; STOMACH MUCOSA;

HUMANS; LYMPHOMA, MUCOSA-ASSOCIATED LYMPHOID TISSUE; LYMPHOMA, NON-HODGKIN; NEOPLASM STAGING; TREATMENT OUTCOME;

EID: 33751246195     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.11-10-1100     Document Type: Review

References (169)

1. Isaacson P, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue: a distinctive type of B-cell lymphoma. Cancer 1983;52:1410-1416.
2. Isaacson P, Wright DH. Extranodal malignant lymphoma arising from mucosa-associated lymphoid tissue. Cancer 1984;53:2515-2524.
3. Harris NL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-1392.
4. Nathwani BN, Anderson JR, Armitage JO et al. Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 1999;17:2486-2492.
5. Wenzel C, Dieckmann K, Fiebiger W et al. CD5 expression in a lymphoma of the mucosa-associated lymphoid tissue (MALT)-type as a marker for early dissemination and aggressive clinical behaviour. Leuk Lymphoma 2001;42:823-829.
6. Wohrer S, Streubel B, Bartsch R et al. Monoclonal immunoglobulin production is a frequent event in patients with mucosa-associated lymphoid tissue. Clin Cancer Res 2004;10:7179-7181.
7. Asatiani E, Cohen P, Ozdemirli M et al. Monoclonal gammopathy in extranodal marginal zone lymphoma (ENMZL) correlates with advanced disease and bone marrow involvement. Am J Hematol 2004;77:144-146.
8. Auer IA, Gascoyne RD, Connors JM et al. t(11;18)(q21;q21) is the most common translocation in MALT lymphomas. Ann Oncol 1997;8:979-985.
9. Ott G, Katzenberger T, Greiner A et al. The t(11;18)(q21;q21) chromosome translocation is a frequent and specific aberration in low-grade but not high-grade malignant non-Hodgkin's lymphomas of the mucosa-associated lymphoid tissue (MALT) type. Cancer Res 1997;57:3944-3948.
10. Streubel B, Lamprecht A, Dierlamm J et al. t(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood 2003;101:2335-2339.
11. Wotherspoon AC, Finn TM, Isaacson P. Trisomy 3 in low-grade B-cell lymphomas of mucosa-associated lymphoid tissue. Blood 1995;85:2000-2004.
12. Dierlamm J, Baens M, Wlodarska I et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas. Blood 1999;93:3601-3609.
13. Morgan JA, Yin Y, Borowsky AD et al. Breakpoints of the t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma lie within or near the previously undescribed gene MALT1 in chromosome 18. Cancer Res 1999;59:6205-6213.
14. Akagi T, Motegi M, Tamura A et al. A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogene 1999;18:5785-5794.
15. Streubel B, Vinatzer U, Lamprecht A et al. T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma. Leukemia 2005;19:652-658.
16. Starostik P, Greiner A, Schultz A et al. Genetic aberrations common in gastric high-grade large B-cell lymphoma. Blood 2000;95:1180-1187.
17. Starostik P, Patzner J, Greiner A et al. Gastric marginal zone B-cell lymphomas of MALT type develop along 2 distinct pathways. Blood 2002;99:3-9.
18. Ye H, Liu H, Raderer M et al. High incidence of t(11;18)(q21;21) in Helicobacter pylori-negative gastric MALT lymphoma. Blood 2003;101:2547-2550.
19. Kaneko Y, Sakurai S, Hironaka M et al. Distinct methylated profiles in Helicobacter pylori dependent and independent gastric MALT lymphomas. Gut 2003;52:641-646.
20. Yeh KH, Kuo SH, Chen LT et al. Nuclear expression of BCL10 or nuclear factor kappa B helps predict Helicobacter pylori-independent status of low-grade gastric mucosa-associated lymphoid tissue lymphomas with or without t(11;18)(q21;q21). Blood 2005;106:1037-1041.
21. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 1997;89:3909-3918.;
22. Raderer M, Streubel B, Woehrer S et al. High relapse rate in patients with MALT lymphoma warrants lifelong follow-up. Clin Cancer Res 2005;11:3349-3352.
23. Wyatt JI, Rathbone BJ. Immune response of the gastric mucosa to Campylobacter pylori. Scand J Gastroenterol 1988;1142(suppl):44-49.
24. Stolte M, Eidt S. Lymphoid follicles in antral mucosa: immune response to Campylobacter pylori? J Clin Pathol 1989;42:1269-1271.
25. Wotherspoon A, Ortiz-Hidalgo C, Falzon M et al. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991;338:1175-1176.
26. Nakamura S, Yao T, Aoyagi K et al. Helicobacter pylori and primary gastric lymphoma. A histopathologic and immunohistochemical analysis of 237 patients. Cancer 1997;79:3-11.
27. Megraud F. Epidemiology of Helicobacter pylori infection. Gastroenterol Clin North Am 1993;22:73-88.
28. Hellmig S, Fischbach W, Goebeler-Kolve ME et al. Association study of a functional Toll-like receptor 4 polymorphism with susceptibility to gastric mucosa-associated lymphoid tissue lymphoma. Leuk Lymphoma 2005;46:869-872.
29. Rollinson S, Levene A, Mensah FK et al. Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity. Blood 2003;102:1007-1011.
30. Ye H, Liu H, Attygalle A et al. Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H. pylori in gastric MALT lymphoma. Blood 2003;102:1012-1018.
31. Doglioni C, Wotherspoon AC, Moschini A et al. High incidence of primary gastric lymphoma in Northeastern Italy. Lancet 1992;339:834-835.
32. Parsonnet J, Hansen S, Rodriguez L et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994;330:1267-1271.
33. Wotherspoon A, Doglioni C, Diss T et al. Regression of primary lowgrade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993;342:575-577.
34. Roggero E, Zucca E, Pinotti G et al. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med 1995;122:767-769.
35. Neubauer A, Thiede C, Morgner A et al. Cure of Helicobacter pylori infection and duration of remission of low-grade gastric mucosa-associated lymphoid tissue lymphoma. J Natl Cancer Inst 1997;89:1350-1355.
36. Steinbach G, Ford R, Glober G et al. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med 1999;131:88-95.
37. Fischbach W, Goebeler-Kolve ME, Dragosics B et al. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut 2004;53:34-37.
38. Hussell T, Isaacson PG, Crabtree JE et al. Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue. J Pathol 1996;178:122-127.
39. Qin Y, Greiner A, Trunk MJ et al. Somatic hypermutation in low-grade mucosa-associated lymphoid tissue-type B-cell lymphoma. Blood 1995;86:3528-3534.
40. Du M, Diss TC, Xu C et al. Ongoing mutation in MALT lymphoma immunoglobulin gene suggests that antigen stimulation plays a role in the clonal expansion. Leukemia 1996;10:1190-1197.
41. Hussell T, Isaacson PG, Crabtree JE et al. Immunoglobulin specificity of low grade B cell gastrointestinal lymphoma of mucosa-associated lymphoid tissue (MALT) type. Am J Pathol 1993;142:285-292.
42. Bende RJ, Aarts WM, Riedl RG et al. Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity. J Exp Med 2005;201:1229-1241.
43. Isaacson PG. Gastric MALT lymphoma: from concept to cure. Ann Oncol 1999;10:637-645.
44. Pinotti G, Zucca E, Roggero E et al. Clinical features, treatment and outcome in a series of 93 patients with low-grade gastric MALT lymphoma. Leuk Lymphoma 1997;26:527-537.
45. Zucca E, Bertoni F, Roggero E et al. The gastric marginal zone B-cell lymphoma of MALT type. Blood 2000;96:410-419.
46. Schechter NR, Portlock CS, Yahalom J. Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone. J Clin Oncol 1998;16:1916-1921.
47. Taal BG, Boot H, van Heerde P et al. Primary non-Hodgkin lymphoma of the stomach: endoscopic pattern and prognosis in low versus high grade malignancy in relation to the MALT concept. Gut 1996;39:556-561.
48. Zucca E, Bertoni F, Roggero E et al. Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach. N Engl J Med 1998;338:804-810.
49. Nakamura S, Aoyagi K, Furuse M et al. B-cell monoclonality precedes the development of gastric MALT lymphoma in Helicobacter pylori-associated chronic gastritis. Am J Pathol 1998;152:1271-1279.
50. Blackledge G, Bush H, Dodge OG et al. A study of gastro-intestinal lymphoma. J Clin Oncol 1979;5:209-219.
51. Musshoff K. Clinical staging classification of non-Hodgkin's lymphomas (author's transl). Strahlentherapie 1977;153:218-221. German.
52. Rohatiner A, d'Amore F, Coiffier B et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol 1994;5:397-400.
53. Wotherspoon A, Doglioni C, Isaacson P. Low-grade gastric B-cell lymphoma of mucosa-associated lymphoid tissue (MALT): a multifocal disease. Histopathology 1992;20:29-34.
54. Du M, Diss T, Xu C et al. Clonal origin of micro-lymphomas in low-grade B-cell gastric MALT lymphoma. J Pathol 1997;181:57 (Abstract).
55. Du MQ, Peng HZ, Dogan A et al. Preferential dissemination of B-cell gastric mucosa-associated lymphoid tissue (MALT) lymphoma to the splenic marginal zone. Blood 1997;90:4071-4077.
56. Briskin M, Winsor-Hines D, Shyjan A et al. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am J Pathol 1997;151:97-110.
57. Kraal G, Schornagel K, Streeter PR et al. Expression of the mucosal vascular addressin, MAdCAM-1, on sinus-lining cells in the spleen. Am J Pathol 1995;147:763-771.
58. Dabaja BS, Ha CS, Wilder RB et al. Importance of esophagogastroduodenoscopy in the evaluation of non-gastrointestinal mucosa-associated lymphoid tissue lymphoma. Cancer J 2003;9:321-324.
59. Bertoni F, Sanna P, Tinguely M et al. Association of gastric and Waldeyer's ring lymphoma: a molecular study. Hematol Oncol 2000;18:15-19.
60. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175-1186.
61. Beal KP, Yeung HW, Yahalom J. FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases. Ann Oncol 2005;16:473-480.
62. Hoffmann M, Kletter K, Becherer A et al. 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma. Oncology 2003;64:336-340.
63. de Jong D, Aleman BM, Taal BG et al. Controversies and consensus in the diagnosis, work-up and treatment of gastric lymphoma: an international survey. Ann Oncol 1999;10:275-280.
64. Zucca E, Roggero E, Pileri S. B-cell lymphoma of MALT type: a review with special emphasis on diagnostic and management problems of low-grade gastric tumours. Br J Haematol 1998;100:3-14.
65. Banks PM, Isaacson PG. MALT lymphomas in 1997. Where do we stand? Am J Clin Pathol 1999;111(suppl 1):S75-S83.
66. Thiede C, Morgner A, Alpen B et al. What role does Helicobacter pylori eradication play in gastric MALT and gastric MALT lymphoma? Gastroenterology 1997;113:S61-S64.
67. Hunt RH. Peptic ulcer disease: defining the treatment strategies in the era of Helicobacter pylori. Am J Gastroenterol 1997;92:36S-40S; discussion 40S-43S.
68. Sackmann M, Morgner A, Rudolph B et al. Regression of gastric MALT lymphoma after eradication of Helicobacter pylori is predicted by endosonographic staging. MALT Lymphoma Study Group. Gastroenterology 1997;113:1087-1090.
69. Ruskone-Fourmestraux A, Lavergne A, Aegerter P et al. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut 2001;48:297-303.
70. Liu H, Ruskon-Fourmestraux A, Lavergne-Slove A et al. Resistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy. Lancet 2001;357:39-40.
71. Inagaki H, Nakamura T, Li C et al. Classification of gastric MALT lymphoma into three distinctive subgroups by responsiveness to H. pylori eradication therapy and detection of API2-MALT1 gene fusion. Blood 2003;102:632a.
72. Cammarota G, Montalto M, Tursi A et al. Helicobacter pylori reinfection and rapid relapse of low-grade B-cell gastric lymphoma. Lancet 1995;345:192.
73. Thiede C, Wundisch T, Alpen B et al. Long-term persistence of monoclonal B cells after cure of Helicobacter pylori infection and complete histologic remission in gastric mucosa-associated lymphoid tissue B-cell lymphoma. J Clin Oncol 2001;19:1600-1069.
74. Bertoni F, Conconi A, Capella C et al. Molecular follow-up in gastric mucosa-associated lymphoid tissue lymphomas: early analysis of the LY03 cooperative trial. Blood 2002;99:2541-2544.
75. Montalban C, Santon A, Redondo C et al. Long-term persistence of molecular disease after histological remission in low-grade gastric MALT lymphoma treated with H. pylori eradication. Lack of association with translocation t(11;18): a 10-year updated follow-up of a prospective study. Ann Oncol 2005;16:1539-1544.
76. Noy A, Yahalom J, Zaretsky L et al. Gastric mucosa-associated lymphoid tissue lymphoma detected by clonotypic polymerase chain reaction despite continuous pathologic remission induced by involved-field radiotherapy. J Clin Oncol 2005;23:3768-3772.
77. Thiede C, Alpen B, Morgner A et al. Ongoing somatic mutations and clonal expansions after cure of Helicobacter pylori infection in gastric mucosa-associated lymphoid tissue B-cell lymphoma. J Clin Oncol 1998;16:3822-3831.
78. Talamonti MS, Dawes LG, Joehl RJ et al. Gastrointestinal lymphoma. A case for primary surgical resection. Arch Surg 1990;125:972-976; discussion 976-977.
79. Bozzetti F, Audisio R, Giardini R et al. Role of surgery in patients with primary non-Hodgkin's lymphoma of the stomach: an old problem revisited. Br J Surg 1993;80:1101-1106.
80. Cogliatti SB, Schmid U, Schumacher U et al. Primary B-cell gastric lymphoma: a clinicopathological study of 145 patients. Gastroenterology 1991;101:1159-1170.
81. Montalban C, Castrillo JM, Abraira V et al. Gastric B-cell mucosa-associated lymphoid tissue (MALT): clinicopathological study and evaluation of the prognostic factors in 143 patients. Ann Oncol 1995;6:355-362.
82. Maor MH, Velasquez WS, Fuller LM et al. Stomach conservation in stages IE and IIE gastric non-Hodgkin's lymphoma. J Clin Oncol 1990;8:266-271.
83. Park HC, Park W, Hahn JS et al. Low grade MALT lymphoma of the stomach: treatment outcome with radiotherapy alone. Yonsei Med J 2002;43:601-606.
84. Shani A, Schutt AJ, Weiland LH. Primary gastric malignant lymphoma followed by gastric adenocarcinoma: report of 4 cases and review of the literature. Cancer 1978;42:2039-2044.
85. Montalban C, Castrillo JM, Lopez-Abente G et al. Other cancers in patients with gastric MALT lymphoma. Leuk Lymphoma 1999;33:161-168.
86. Copie-Bergman C, Locher C, Levy M et al. Metachronous gastric MALT lymphoma and early gastric cancer: is residual lymphoma a risk factor for the development of gastric carcinoma? Ann Oncol 2005;16:1232-1236.
87. Fung CY, Grossbard ML, Linggood RM et al. Mucosa-associated lymphoid tissue lymphoma of the stomach: long term outcome after local treatment. Cancer 1999;85:9-17.
88. Witzig T, Gordon L, Emmanouilides C et al. Safety and efficacy of Zevalin in four patients with mucosa associated lymphoid tissue (MALT) lymphoma. Blood 2001;98:254b.
89. Hammel P, Haioun C, Chaumette MT et al. Efficacy of single-agent chemotherapy in low-grade B-cell mucosa-associated lymphoid tissue lymphoma with prominent gastric expression. J Clin Oncol 1995;13:2524-2529.
90. Levy M, Copie-Bergman C, Gameiro C et al. Prognostic value of translocation t(11;18) in tumoral response of low-grade gastric lymphoma of mucosa-associated lymphoid tissue type to oral chemotherapy. J Clin Oncol 2005;23:5061-5066.
91. Nakamura S, Matsumoto T, Suekane H et al. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment. Cancer 2005;104:532-540.
92. Bertoni F, Conconi A, Capella C et al. Gastric MALT lymphomas prospective LY03 randomized cooperative trial: preliminary results of the molecular follow up. Blood 2001;98:767a.
93. Jager G, Neumeister P, Brezinschek R et al. Treatment of extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue type with cladribine: a phase II study. J Clin Oncol 2002;20:3872-3877.
94. Raderer M, Jager G, Brugger S et al. Rituximab for treatment of advanced extranodal marginal zone B cell lymphoma of the mucosa-associated lymphoid tissue lymphoma. Oncology 2003;65:306-310.
95. Conconi A, Martinelli G, Thieblemont C et al. Clinical activity of rituximab in extranodal marginal zone B-cell lymphoma of MALT type. Blood 2003;102:2741-2745.
96. Martinelli G, Laszlo D, Ferreri AJ et al. Clinical activity of rituximab in gastric marginal zone non-Hodgkin's lymphoma resistant to or not eligible for anti-Helicobacter pylori therapy. J Clin Oncol 2005;23:1979-1983.
97. Coiffier B, Lepage E, Brière J et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002;346:235-242.
98. de Jong D, Boot H, Taal B. Histological grading with clinical relevance in gastric mucosa-associated lymphoid tissue (MALT) lymphoma. Recent Results Cancer Res 2000;156:27-32.
99. Bayerdorffer E, Neubauer A, Rudolph B et al. Regression of primary gastric lymphoma of mucosa-associated lymphoid tissue type after cure of Helicobacter pylori infection. MALT Lymphoma Study Group. Lancet 1995;345:1591-1594.
100. Peng H, Du M, Diss TC et al. Genetic evidence for a clonal link between low and high-grade components in gastric MALT B-cell lymphoma. Histopathology 1997;30:425-429.
101. de Jong D, Boot H, van Heerde P et al. Histological grading in gastric lymphoma: pretreatment criteria and clinical relevance. Gastroenterology 1997;112:1466-1474.
102. Thieblemont C, Bastion Y, Berger F et al. Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients. J Clin Oncol 1997;15:1624-1630.
103. Castrillo JM, Montalban C, Obeso G et al. Gastric B-cell mucosa associated lymphoid tissue lymphoma: a clinicopathological study in 56 patients. Gut 1997;33:1307-1311.
104. Ranaldi R, Goteri G, Baccarini MG et al. A clinicopathological study of 152 surgically treated primary gastric lymphomas with survival analysis of 109 high grade tumours. J Clin Pathol 2002;55:346-351.
105. Chen LT, Lin JT, Shyu RY et al. Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach. J Clin Oncol 2001;19:4245-4251.
106. Kuo SH, Chen LT, Chen CL et al. Expression of CD86 and increased infiltration of NK cells are associated with Helicobacter pylori-dependent state of early stage high-grade gastric MALT lymphoma. World J Gastroenterol 2005;11:4357-4362.
107. Ferreri AJ, Guidoboni M, Ponzoni M et al. Evidence for an association between Chlamydia psittaci and ocular adnexal lymphomas. J Natl Cancer Inst 2004;96:586-594.
108. Mulder MM, Heddema ER, Pannekoek Y et al. No evidence for an association of ocular adnexal lymphoma with Chlamydia psittaci in a cohort of patients from the Netherlands. Leuk Res 2006;30:1305-1307.
109. Rosado MF, Byrne GE Jr, Ding F et al. Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci. Blood 2006;107:467-472.
110. Cerroni L, Zochling N, Putz B et al. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cutan Pathol 1997;24:457-461.
111. Roggero E, Zucca E, Mainetti C et al. Eradication of Borrelia burgdorferi infection in primary marginal zone B-cell lymphoma of the skin. Hum Pathol 2000;31:263-268.
112. Luppi M, Longo G, Ferrari MG et al. Additional neoplasms and HCV infection in low-grade lymphoma of MALT type. Br J Haematol 1996;94:373-375.
113. Ascoli V, Lo Coco F, Artini M et al. Extranodal lymphomas associated with hepatitis C virus infection. Am J Clin Pathol 1998;109:600-609.
114. Zucca E, Roggero E, Maggi-Solca N et al. Prevalence of Helicobacter pylori and hepatitis C virus infections among non-Hodgkin's lymphoma patients in Southern Switzerland. Haematologica 2000;85:147-153.
115. Lecuit M, Abachin E, Martin A et al. Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med 2004;350:239-248.
116. + MALT lymphoma remission induced by highly active antiretroviral therapy alone. Eur J Haematol 2005;74:70-72.
117. Diss TC, Wotherspoon AC, Speight P et al. B-cell monoclonality, Epstein Barr virus, and t(14;18) in myoepithelial sialadenitis and low grade B-cell MALT lymphoma of the parotid gland. Am J Surg Pathol 1995;19:531-536.
118. Ansell SM, Grant CS, Habermann TM. Primary thyroid lymphoma. Semin Oncol 1999;26:316-323.
119. Zinzani PL, Magagnoli M, Galieni P et al. Nongastrointestinal low-grade mucosa-associated lymphoid tissue lymphoma: analysis of 75 patients. J Clin Oncol 1999;17:1254-1258.
120. Zucca E, Conconi A, Roggero E et al. Non-gastric MALT lymphomas: a survey of 369 European patients. The International Extranodal Lymphoma Study Group. Ann Oncol 2000;11(suppl 1):99.
121. Zucca E, Conconi A, Pedrinis E et al. Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue. Blood 2003;101:2489-2495.
122. Falzon M, Isaacson PG. The natural history of benign lymphoepithelial lesion of the salivary gland in which there is a monoclonal population of B cells. A report of two cases. Am J Surg Pathol 1991;15:59-65.
123. Hsi ED, Siddiqui J, Schnitzer B et al. Analysis of immunoglobulin heavy chain gene rearrangement in myoepithelial sialadenitis by polymerase chain reaction. Am J Clin Pathol 1996;106:498-503.
124. Isaacson PG. Mucosa-associated lymphoid tissue lymphoma. Semin Hematol 1999;36:139-147.
125. Ambrosetti A, Zanotti R, Pattaro C et al. Most cases of primary salivary mucosa-associated lymphoid tissue lymphoma are associated either with Sjoegren syndrome or hepatitis C virus infection. Br J Haematol 2004;126:43-49.
126. Wotherspoon AC, Diss TC, Pan LX et al. Primary low-grade B-cell lymphoma of the conjunctiva: a mucosa-associated lymphoid tissue type lymphoma. Histopathology 1993;23:417-424.
127. Hardman-Lea S, Kerr-Muir M, Wotherspoon AC et al. Mucosal-associated lymphoid tissue lymphoma of the conjunctiva. Arch Ophthalmol 1994;112:1207-1212.
128. Minasian MC, Sharma A, Richman PI et al. Conjunctival MALT lymphoma: an unusual cause of red eye. Postgrad Med J 1999;75:423-424.
129. Lee DH, Sohn HW, Park SH et al. Bilateral conjunctival mucosa-associated lymphoid tissue lymphoma misdiagnosed as allergic conjunctivitis. Cornea 2001;20:427-429.
130. Uno T, Isobe K, Shikama N et al. Radiotherapy for extranodal, marginal zone, B-cell lymphoma of mucosa-associated lymphoid tissue originating in the ocular adnexa: a multiinstitutional, retrospective review of 50 patients. Cancer 2003;98:865-871.
131. Agulnik M, Tsang R, Baker MA et al. Malignant lymphoma of mucosa-associated lymphoid tissue of the lacrimal gland: case report and review of literature. Am J Clin Oncol 2001;24:67-70.
132. Blasi MA, Gherlinzoni F, Calvisi G et al. Local chemotherapy with interferon-alpha for conjunctival mucosa-associated lymphoid tissue lymphoma: a preliminary report. Ophthalmology 2001;108:559-562.
133. Ferreri AJ, Ponzoni M, Guidoboni M et al. Regression of ocular adnexal lymphoma after Chlamydia psittaci-eradicating antibiotic therapy. J Clin Oncol 2005;23:5067-5073.
134. Li G, Hansmann ML, Zwingers T et al. Primary lymphomas of the lung: morphological, immunohistochemical and clinical features. Histopathology 1990;16:519-531.
135. Fiche M, Caprons F, Berger F et al. Primary pulmonary non-Hodgkin's lymphomas. Histopathology 1995;26:529-537.
136. Herbert A, Walters MT, Cawley MI et al. Lymphocytic interstitial pneumonia identified as lymphoma of mucosa associated lymphoid tissue. J Pathol 1985;146:129-138.
137. Nicholson AG, Wotherspoon AC, Jones A et al. Pulmonary B-cell non-Hodgkin's lymphoma associated with autoimmune disorders: a clinicopathological review of six cases. Eur Respir J 1996;9:2022-2025.
138. King LJ, Padley SP, Wotherspoon AC et al. Pulmonary MALT lymphoma: imaging findings in 24 cases. Eur Radiol 2000;10:1932-1938.
139. Cordier JF, Chailleux E, Lauque D et al. Primary pulmonary lymphomas. Chest 1993;103:201-208.
140. Nicholson AG, Wotherspoon AC, Diss TC et al. Pulmonary B-cell non-Hodgkin's lymphomas: the value of immunohistochemistry and gene analysis in diagnosis. Histopathology 1995;26:395-403.
141. Gospodarowicz MK, Sutcliffe SB. The extranodal lymphomas. Semin Radiat Oncol 1995;5:281-300.
142. Habermann TM, Ryu JH, Inwards DJ et al. Primary pulmonary lymphoma. Semin Oncol 1999;26:307-315.
143. Ali R, Ozkalemkas F, Ozcelik T et al. Successful treatment of BALT lymphoma with combined chemotherapy. Thorax 2003;58:368-369.
144. Ferraro P, Trastek VF, Adlakha H et al. Primary non-Hodgkin's lymphoma of the lung. Ann Thorac Surg 2000;69:993-997.
145. Zinzani PL, Tani M, Gabriele A et al. Extranodal marginal zone B-cell lymphoma of MALT-type of the lung: single-center experience with 12 patients. Leuk Lymphoma 2003;44:821-824.
146. Ahmed S, Kussick SJ, Siddiqui AK et al. Bronchial-associated lymphoid tissue lymphoma: a clinical study of a rare disease. Eur J Cancer 2004;40:1320-1326.
147. Chong EA, Svoboda J, Cherian S et al. Regression of pulmonary MALT lymphoma after treatment with rituximab. Leuk Lymphoma 2005;46:1383-1386.
148. Kees M, Raderer M, Metz-Schimmerl S et al. Very good partial response in a patient with MALT-lymphoma of the lung after treatment with low-dose thalidomide. Leuk Lymphoma 2005;46:1379-1382.
149. Holm LE, Blomgren H, Lowhagen T. Cancer risks in patients with chronic lymphocytic thyroiditis. N Engl J Med 1985;312:601-604.
150. Matsuzuka F, Miyauchi A, Katayama S et al. Clinical aspects of primary thyroid lymphoma: Diagnosis and treatment based on our experience of 119 cases. Thyroid 1993;3:93-99.
151. Saxena A, Alport EC, Moshynska O et al. Clonal B cell populations in a minority of patients with Hashimoto's thyroiditis. J Clin Pathol 2004;57:1258-1263.
152. Skacel M, Ross CW, Hsi ED. A reassessment of primary thyroid lymphoma: high-grade MALT-type lymphoma as a distinct subtype of diffuse large B-cell lymphoma. Histopathology 2000;37:10-18.
153. Gogas J, Kouskos E, Markopoulos C et al. Mucosa-associated lymphoid tissue thyroid lymphoma: a rare but not aggressive tumor. Eur J Surg 2002;168:572-574.
154. Arima N, Tsudo M. Extragastric mucosa-associated lymphoid tissue lymphoma showing the regression by Helicobacter pylori eradication therapy. Br J Haematol 2003;120:790-792.
155. Rijlaarsdam JU, van der Putte SC, Berti E et al. Cutaneous immunocytomas: a clinicopathologic study of 26 cases. Histopathology 1993;23:117-125.
156. Cerroni L, Signoretti S, Hofler G et al. Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma. Am J Surg Pathol 1997;21:1307-1315.
157. Hugh JC, Jackson FI, Hanson J et al. Primary breast lymphoma. An immunohistologic study of 20 new cases. Cancer 1990;66:2602-2611.
158. Giardini R, Piccolo C, Rilke F. Primary non-Hodgkin's lymphomas of the female breast. Cancer 1992;69:725-735.
159. Schwartz I, Strauchen J. Lymphocytic mastopathy. An autoimmune disease of the breast. Am J Clin Pathol 1990;93:725-730.
160. Brogi E, Harris NL. Lymphomas of the breast: pathology and clinical behavior. Semin Oncol 1999;26:357-364.
161. Mattia AR, Ferry JA, Harris NL. Breast lymphoma. A B-cell spectrum including the low-grade B-cell lymphoma of mucosa associated lymphoid tissue. Am J Surg Pathol 1993;17:574-587.
162. Rottnek M, Strauchen J, Moore F et al. Primary dural mucosa-associated lymphoid tissue-type lymphoma: case report and review of the literature. J Neurooncol 2004;68:19-23.
163. Kumar S, Kumar D, Kaldjian EP et al. Primary low-grade B-cell lymphoma of the dura: a mucosa associated lymphoid tissue-type lymphoma. Am J Surg Pathol 1997;21:81-87.
164. Kambham N, Chang Y, Matsushima AY. Primary low-grade B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) arising in dura. Clin Neuropathol 1998;17:311-317.
165. Itoh T, Shimizu M, Kitami K et al. Primary extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type in the CNS. Neuropathology 2001;21:174-180.
166. Sanjeevi A, Krishnan J, Bailey PR et al. Extranodal marginal zone B-cell lymphoma of MALT type involving the cavernous sinus. Leuk Lymphoma 2001;42:1133-1137.
167. Kempton CL, Kurtin PJ, Inwards DJ et al. Malignant lymphoma of the bladder: evidence from 36 cases that low-grade lymphoma of the MALT-type is the most common primary bladder lymphoma. Am J Surg Pathol 1997;21:1324-1333.
168. Bates AW, Norton AJ, Baithun SI. Malignant lymphoma of the urinary bladder: a clinicopathological study of 11 cases. J Clin Pathol 2000;53:458-461.
169. Tuzel E, Mungan MU, Yorukoglu K et al. Primary renal lymphoma of mucosa-associated lymphoid tissue. Urology 2003;61:463.